Remove 2017 Remove Healthcare Remove Insurance Remove Sales
article thumbnail

Merck settles with insurers regarding a $1.4 billion claim over NotPetya damages

Security Affairs

Merck has resolved a dispute with insurers regarding a $1.4 Merck and its insurers have agreed with a $1.4 known as Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company. billion insurance claim for the losses caused by the NotPetya attack that took place in 2017.

Insurance 113
article thumbnail

Regulatory Update: NAIC Summer 2018 National Meeting

Data Matters

The National Association of Insurance Commissioners (NAIC) held its Summer 2018 National Meeting in Boston, Massachusetts, from August 4 to 7, 2018. NAIC Continues its Evaluation of Insurers’ Use of Big Data . The NAIC is also considering insurers’ use of big data in underwriting life insurance products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2019 end-of-year review part 1: January to June

IT Governance

Victims of Equifax’s 2017 data breach were given the go-ahead to launch a class-action lawsuit. It was yet another case of point-of-sale vulnerabilities being exposed, as the US fails to expedite its transition to chip and PIN. Sensitive data belonging to hundreds of German politicians and public figures was published online.

article thumbnail

The Good, Bad, And The Ugly: Key Takeaways From California’s New Privacy Law

Privacy and Cybersecurity Law

In the aftermath of the Cambridge Analytica scandal, and in the footsteps of Europe’s General Data Protection Regulation (“GDPR”), California privacy advocates introduced a ballot initiative on October 12, 2017 called “The Consumer Right to Privacy Act of 2018” (No. The ballot initiative largely mirrored what is now the language in the CCPA.

Privacy 58
article thumbnail

Data Secrets to A Successful Drug Launch

Reltio

Research indicates that 81% of future drug sales performance is determined by actions taken during clinical development and early commercialization phase. For example, when a new drug is launched, it helps track sales performance compared to projections so that you can adjust strategies whenever needed.

MDM 70